Swiss Medical Weekly (Mar 2009)

Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting

  • KM Erny-Albrecht,
  • E Erdmann

DOI
https://doi.org/10.4414/smw.2009.12381
Journal volume & issue
Vol. 139, no. 1112

Abstract

Read online

No abstracts available.

Keywords